EirGen Pharma Overview

  • Founded
  • 2005

Founded
  • Status
  • Acquired/​Merged

  • Employees
  • 200

Employees
  • Latest Deal Type
  • M&A

  • Financing Rounds
  • 2

EirGen Pharma General Information

Description

Developer and manufacturer of high potency, high barrier to entry solid dose products for the pharmaceutical market. The company is fully licensed to manufacture oncology, cytotoxic, steroidal and immunosuppressant molecules in a purpose built high containment facility.

Contact Information

Website
www.eirgen.com
Ownership Status
Acquired/Merged
(Operating Subsidiary)
Financing Status
Corporate Backed or Acquired
Primary Industry
Distributors/Wholesale
Other Industries
Drug Discovery
Pharmaceuticals
Parent Company
Primary Office
  • Westside Business Park
  • Old Kilmeaden Road
  • Waterford
  • Ireland
+353 (051) 000 000

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

EirGen Pharma Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore EirGen Pharma‘s full profile, request access.

Request a free trial

EirGen Pharma Patents

EirGen Pharma Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
CA-3181945-A1 Hard capsule dosage form and uses thereof Pending 31-May-2020 0000000000
AU-2021285494-A1 Hard capsule dosage form and uses thereof Pending 31-May-2020 0000000000
CA-3176559-A1 25-hydroxyvitamin d for the treatment of sars-cov-2 infection Pending 06-Apr-2020 0000000000
US-20210308151-A1 Activating endogenous antimicrobials to treat sars-cov-2 infection Pending 06-Apr-2020 0000000000
EP-4096660-A1 Tetrahydrocyclopenta[b]indole compounds for the treatment of renal disease Pending 27-Jan-2020 A61K31/404
To view EirGen Pharma’s complete patent history, request access »

EirGen Pharma Executive Team (3)

Name Title Board Seat Contact Info
Tom Brennan Chief Technology Officer & Co-Founder
Damien Burke Head, Operations
You’re viewing 2 of 3 executive team members. Get the full list »

EirGen Pharma Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

EirGen Pharma Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore EirGen Pharma‘s full profile, request access.

Request a free trial